NASDAQ: CADL - Candel Therapeutics, Inc.

Rentabilité sur six mois: +29.08%
Secteur: Healthcare

Calendrier des promotions Candel Therapeutics, Inc.

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise

Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. It develops CAN-2409, which is in Phase II clinical trials for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the treatment of lung cancer, as well as has completed Phase Ib/II clinical trials for the treatment of high-grade glioma. The company also develops CAN-3110, which is in Phase I clinical trials for the treatment of recurrent glioblastoma.

Plus de détails
It also develops the?enLIGHTEN Discovery Platform, a systematic, iterative HSV-based discovery platform leveraging human biology and advanced analytics to create new viral immunotherapies for solid tumors. The company was formerly known as Advantagene, Inc. and changed its name to Candel Therapeutics, Inc. in November 2020. Candel Therapeutics, Inc. was incorporated in 2003 and is based in Needham, Massachusetts.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

Цена ао 1.49
Выручка 0.000125
EBITDA -0.0076
P/S 1829.26
P/BV 3.57
EV/EBITDA 0.6279
ISIN US1374041093
Сайт https://www.candeltx.com
Число акций ао 0.02894 млрд
Валюта usd
IPO date 2021-07-27
Sector Health Care
Industry Biotechnology
Валюта отчета usd
Changement de prix par jour: -2.09% (6.71)
Changement de prix par semaine: -8.88% (7.21)
Changement de prix par mois: +4.12% (6.31)
Changement de prix sur 3 mois: +13.67% (5.78)
Changement de prix sur six mois: +29.08% (5.09)
Changement de prix par an: +606.45% (0.93)
Evolution du prix sur 3 ans: -33.84% (9.93)
Evolution des prix depuis le début de l'année: +606.45% (0.93)
Tous les paramètres

Sous-estimation

Nom Signification Grade
P/S 1064.07 1
P/BV 2.59 6
P/E 0 0
EV/EBITDA -0.5468 0
Total: 3.5

Efficacité

Nom Signification Grade
ROA, % -90.98 0
ROE, % -297.68 0
Total: 0

Dividendes

Nom Signification Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Devoir

Nom Signification Grade
Debt/EBITDA -0.5859 10
Total: 9.8

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % -75.2 0
Rentabilité Ebitda, % 389.36 10
Rentabilité EPS, % 205.63 10
Total: 8
Plus de détails

Établissements Volume Partager, %
Northpond Ventures, Llc 1935215 6.59
Sands Capital Ventures, LLC 811737 2.77
Vanguard Group Inc 425749 1.45
FMR, LLC 298384 1.02
Geode Capital Management, LLC 139253 0.47
Bridgeway Capital Management, Inc. 132595 0.45
Baystate Wealth Management LLC 76910 0.26
Blackrock Inc. 49285 0.17
OneDigital Investment Advisors LLC 29783 0.1
State Street Corporation 27600 0.09

ETF Partager, % Rentabilité pour l'année, % Dividendes, %
ProShares Hedge Replication ETF 0.00093 5.9237999659878 1.47892
iShares Micro-Cap ETF 0.03787 36.318555985322 1.54048
iShares Russell 2000 Growth ETF 0.01119 38.042556988 0.6026
ProShares UltraPro Russell2000 0.00323 89.821266282945 1.47873
Vanguard Russell 3000 ETF 0 31.87314172448 1.43817
Vanguard Russell 2000 Growth ETF 0.01 39.350070246167 0.60264
Vanguard Russell 2000 ETF 0 35.648084105685 1.48801



Superviseur Titre d'emploi Paiement Année de naissance
Dr. Seshu Tyagarajan Ph.D. Chief Technical & Development Officer 335.27k 1968 (56 années)
Dr. Francesca Barone M.D., Ph.D. Chief Scientific Officer 506.76k 1978 (46 années)
Ms. Ileen B. Winick Chief People Officer N/A
Ms. Susan Stewart J.D., L.L.M. Chief Regulatory Officer N/A 1961 (63 année)
Dr. William Garrett Nichols M.D., M.S. Chief Medical Officer N/A 1969 (55 années)
Mr. Charles Schoch Interim CFO, Principal Accounting Officer, Treasurer & Secretary N/A 1985 (39 années)
Dr. Paul-Peter Tak FOCIS, M.D., Ph.D. President, CEO & Director 1961 (63 année)

Adresse: United States, Needham. MA, 117 Kendrick Street - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.candeltx.com